Editor-in-Chief: Godefridus J. Peters
Journal Rank: Impact Factor 2024: 5.2 - Q1 (ONCOLOGY); CiteScore 2024: 8.3 - Q1 [Pharmacology(medical)]
Median time to first editorial decision: 9 days

Cancer Drug Resistance

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN

Articles

Most Recent | Most Viewed | Most Downloaded

RCC1 knockdown sensitizes drug-resistant colorectal cancer to 5-fluorouracil or doxorubicin by impairing DNA repair

Open Access Original Article DOI: 10.20517/cdr.2025.159 9 Nov 2025
Views: Downloads:
Download PDF

Novel FAK inhibitors suppress tumor growth and reverse EGFR-TKI resistance in non-small cell lung cancer

Open Access Original Article DOI: 10.20517/cdr.2025.139 4 Nov 2025
Views: Downloads:
Download PDF

Circular RNA-based liquid biopsy: a promising approach for monitoring drug resistance in cancer

Open Access Review DOI: 10.20517/cdr.2025.142 29 Oct 2025
Views: Downloads:
Download PDF

Targeting tumor-draining lymph node to overcome resistance to cancer immunotherapy: an update

Open Access Review DOI: 10.20517/cdr.2025.126 23 Oct 2025
Views: Downloads:
Download PDF

Recent progress on tyrosine kinase inhibitors resistance in renal cell carcinoma: another brick in the wall?

Open Access Review DOI: 10.20517/cdr.2025.157 14 Oct 2025
Views: Downloads:
Download PDF

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

Open Access Review DOI: 10.20517/cdr.2023.16 19 Jun 2023
Views: Downloads:
Download PDF

Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects

Open Access Review DOI: 10.20517/cdr.2022.136 28 Apr 2023
Views: Downloads:
Download PDF

Anti-BCMA novel therapies for multiple myeloma

Open Access Review DOI: 10.20517/cdr.2022.138 21 Mar 2023
Views: Downloads:
Download PDF

Submission Deadline: 15 Jul 2026

Published articles: 0

Mechanisms of Resistance in Solid Tumors and Precision Medicine Approaches

Submission Deadline: 31 May 2026

Published articles: 0

Coming soon.

For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Articles Collection
Prestigious Honor, Global Impact: 58 CDR Editorial Board Members Ranked Among World's Top 2% Scientists, Reinforcing the Journal's Leadership in the Field
Advancing the Fight Against Cancer Drug Resistance Together: Share Your Findings and Enjoy Anniversary Savings!
Marking a 13% rise, CDR continues to lead the field of cancer drug resistance.
This marks a notable 25.8% increase from last year's score of 6.6, underscoring the CDR's rising academic impact and global recognition.
We are thrilled to announce that Prof. Baiyong Shen, a globally recognized leader in pancreatic cancer research and Vice President of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, has officially joined Cancer Drug Resistance as an Associate Editor.

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN

Submission Deadline: 15 Jul 2026

Published articles: 0

Mechanisms of Resistance in Solid Tumors and Precision Medicine Approaches

Submission Deadline: 31 May 2026

Published articles: 0

Coming soon.

Articles Collection
Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/